Daniel Marcel Legault

Daniel Marcel Legault is a declared insider of Antibe Therapeutics Inc., with filings sourced from SEDI. Between 10 June 2013 and 7 March 2024, the trades on record add up to 46 filings.

Both buying and selling appear: 17 purchases worth €198k, against 12 sales worth €1.3M. Sales outweigh purchases by €1.2M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 4 option exercises. 2024 to date brings 1 purchase and no sales.

Half of the purchases are above €10k and half below. None of the 12 purchases we analysed coincided with buying by another insider of the same company within 30 days.

The latest filing, published on 7 March 2024, reports an open-market purchase of €6,789 in Antibe Therapeutics Inc. Typically, a trade is published a median of 2 days after it takes place. That lag is the time during which only the insider knows about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.